A patient with maculopapular rash and lichenoid skin damage caused by ponatinib
Ingrid Anna Teigen1, Anna Kristine Myrmel Sæle2,3, Håkon Reikvam4,5
1Department of Pharmacology, Haukeland University Hospital, N-5021 Bergen, Norway.
The Journal of International Medical Research
|April 4, 2020
Abstract
No abstract available in PubMed .
Keywords:
BCR-ABL1Chronic myelogenous leukemiaponatinibretinoidskin reactiontyrosine kinase inhibitorMore Related Videos
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.6K
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
2.2K
